{"id":273265,"date":"2026-09-28T10:11:18","date_gmt":"2026-09-28T04:41:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=273265"},"modified":"2026-09-28T10:11:18","modified_gmt":"2026-09-28T04:41:18","slug":"fortis-healthcare-forensic-audit","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/","title":{"rendered":"Fortis Says It Is a &#8216;Complete Stranger&#8217; to the Daiichi Dispute as the Supreme Court Clears a Forensic Audit"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Fortis at Rs 821, down 1.69%. Supreme Court cleared the audit on 25 Sep. RSI 22.3, deeply oversold. Market cap Rs 63,047 crore. P\/E 58.9 vs industry 67.7.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Fortis Healthcare forensic audit was cleared on 25 September 2026 when the Supreme Court declined to interfere with the Delhi High Court&#8217;s 31 August order, while stating that the High Court&#8217;s observations against the company were only tentative. Fortis says it was a complete stranger to the Daiichi Sankyo dispute with the Singh brothers, was never party to the arbitration and has had no liability, penalty or fine imposed on it. The shares fell 1.69 percent to Rs 821 on Monday, a mild reaction that suggests investors are waiting for the audit&#8217;s scope and findings before pricing in any direct liability.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/fortis\/fortis-healthcare-share-price-today\">Fortis Healthcare<\/a> said in a disclosure to the stock exchanges, reported on 27 September, that it had no role in the alleged dissipation of its former promoters&#8217; shareholding, and that it was confident an independent audit would confirm this. The disclosure followed a Supreme Court order two days earlier that disposed of the company&#8217;s special leave petition against the Delhi High Court&#8217;s direction for a forensic audit.<\/p>\n<p>The audit is linked to Daiichi Sankyo&#8217;s efforts to enforce a 2016 arbitral award against Malvinder and Shivinder Singh, the former promoters of both Ranbaxy Laboratories and Fortis. The stock opened lower, and at Rs 821 it was down Rs 14.10 on the day.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=fortis-healthcare-forensic-audit\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_the_Supreme_Court_Decided_in_the_Fortis_Healthcare_Forensic_Audit_Case\" title=\"What the Supreme Court Decided in the Fortis Healthcare Forensic Audit Case\">What the Supreme Court Decided in the Fortis Healthcare Forensic Audit Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_Fortis_Says_About_the_Fortis_Healthcare_Forensic_Audit\" title=\"What Fortis Says About the Fortis Healthcare Forensic Audit\">What Fortis Says About the Fortis Healthcare Forensic Audit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#Background_How_the_Dispute_Reached_Fortis\" title=\"Background: How the Dispute Reached Fortis\">Background: How the Dispute Reached Fortis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#Fortis_Healthcare_Share_Price_Levels_and_Valuation\" title=\"Fortis Healthcare Share Price Levels and Valuation\">Fortis Healthcare Share Price Levels and Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_Could_Change_From_Here\" title=\"What Could Change From Here\">What Could Change From Here<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_did_the_Supreme_Court_decide_about_the_Fortis_Healthcare_forensic_audit\" title=\"What did the Supreme Court decide about the Fortis Healthcare forensic audit?\">What did the Supreme Court decide about the Fortis Healthcare forensic audit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_is_Fortis_Healthcares_position_in_the_Daiichi_dispute\" title=\"What is Fortis Healthcare&#8217;s position in the Daiichi dispute?\">What is Fortis Healthcare&#8217;s position in the Daiichi dispute?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#Why_is_Daiichi_Sankyo_behind_the_Fortis_Healthcare_forensic_audit\" title=\"Why is Daiichi Sankyo behind the Fortis Healthcare forensic audit?\">Why is Daiichi Sankyo behind the Fortis Healthcare forensic audit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#How_did_the_Fortis_share_price_react_to_the_Fortis_Healthcare_forensic_audit_order\" title=\"How did the Fortis share price react to the Fortis Healthcare forensic audit order?\">How did the Fortis share price react to the Fortis Healthcare forensic audit order?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#Is_Fortis_Healthcare_oversold\" title=\"Is Fortis Healthcare oversold?\">Is Fortis Healthcare oversold?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_is_Fortis_Healthcares_valuation\" title=\"What is Fortis Healthcare&#8217;s valuation?\">What is Fortis Healthcare&#8217;s valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/fortis-healthcare-forensic-audit\/#What_should_investors_watch_next_in_the_Fortis_Healthcare_forensic_audit\" title=\"What should investors watch next in the Fortis Healthcare forensic audit?\">What should investors watch next in the Fortis Healthcare forensic audit?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_the_Supreme_Court_Decided_in_the_Fortis_Healthcare_Forensic_Audit_Case\"><\/span><strong>What the Supreme Court Decided in the Fortis Healthcare Forensic Audit Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On 25 September, the Supreme Court declined to set aside the Delhi High Court&#8217;s 31 August order directing a forensic audit of Fortis in the matter of Daiichi Sankyo Company Limited versus Malvinder Mohan Singh and others. The court said the audit must be conducted independently and without being influenced by the High Court&#8217;s observations.<\/p>\n<p>It also clarified that those observations, including passages criticising the company, were tentative and made only for the purpose of making out a case for an audit. The bench questioned whether Fortis management could have been unaware of the status quo orders that covered the Singh brothers&#8217; shareholding, which is the point Daiichi&#8217;s counsel pressed in opposing the petition.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/stocks-to-watch-today-25092026\">Stocks to Watch Today: PB Fintech, Mazagon Dock, More<\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_Fortis_Says_About_the_Fortis_Healthcare_Forensic_Audit\"><\/span><strong>What Fortis Says About the Fortis Healthcare Forensic Audit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Fortis has made five points in its disclosure. It says it was a complete stranger to the underlying dispute, had no role in the alleged dissipation of the promoters&#8217; shareholding, was never a party to the arbitration proceedings, is neither a judgment debtor nor a garnishee in respect of Daiichi&#8217;s decree, and has had no liability, penalty or fine imposed on it by the High Court.<\/p>\n<p>The company added that it is confident an independent forensic audit will attest to these facts. That position is consistent with the Supreme Court&#8217;s clarification, but it does not remove the risk that the audit examines transactions the company was involved in.<\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Background_How_the_Dispute_Reached_Fortis\"><\/span><strong>Background: How the Dispute Reached Fortis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Daiichi Sankyo bought a controlling stake in Ranbaxy from the Singh brothers in 2008 and later alleged that information was concealed during the sale. A Singapore arbitration tribunal ruled in its favour in 2016, and the award is reported at about Rs 3,500 crore, which it is now trying to enforce.<\/p>\n<p>Enforcement widened to transactions involving the brothers&#8217; Fortis shares, which Daiichi alleges were dissipated despite assurances given during the proceedings. In September 2022, the Supreme Court had ordered a forensic audit of Fortis&#8217;s share sale to IHH Healthcare, and the stock fell as much as 18 percent intraday on that day. The current one-day fall of 1.69 percent is far milder, which suggests the market sees limited direct exposure for now.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Live Prices, RSI and Fundamentals on Univest Screener<\/strong><\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Fortis_Healthcare_Share_Price_Levels_and_Valuation\"><\/span><strong>Fortis Healthcare Share Price Levels and Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;\">Metric<\/th>\n<th style=\"text-align:left;\">Value<\/th>\n<\/tr>\n<tr>\n<td>Price at time of update<\/td>\n<td>Rs 821.00, down Rs 14.10 (1.69%)<\/td>\n<\/tr>\n<tr>\n<td>Market capitalisation<\/td>\n<td>Rs 63,047 crore<\/td>\n<\/tr>\n<tr>\n<td>P\/E ratio<\/td>\n<td>58.89 vs industry 67.71<\/td>\n<\/tr>\n<tr>\n<td>Return on equity<\/td>\n<td>10.53%<\/td>\n<\/tr>\n<tr>\n<td>Debt-to-equity<\/td>\n<td>0.35<\/td>\n<\/tr>\n<tr>\n<td>RSI (14-day)<\/td>\n<td>22.3<\/td>\n<\/tr>\n<tr>\n<td>SuperTrend (bearish) resistance<\/td>\n<td>Rs 895.5<\/td>\n<\/tr>\n<tr>\n<td>20-day average<\/td>\n<td>Rs 891.6<\/td>\n<\/tr>\n<\/table>\n<p>An RSI of 22.3 places the stock deep in oversold territory, and the price is about 7 percent below its 20-day average, while the MACD line of minus 17.4 sits below its signal line. Oversold readings can persist in a downtrend, but they also mean that much of the negative news has already been reflected in the price.<\/p>\n<p>The valuation is at a discount to the hospital industry at 58.9 times earnings against 67.7, though a premium multiple for the sector already assumes stable operations, which is the assumption an adverse audit finding would challenge.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/intraday-stocks-for-today-25092026\">Intraday Stocks for Today: 3 Setups From Vikran, Divi&#8217;s Labs and Olectra<\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_Could_Change_From_Here\"><\/span><strong>What Could Change From Here<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Appointment and scope: who conducts the audit and which transactions it covers will decide how close it gets to the company&#8217;s own dealings.<\/li>\n<li>Timeline: a lengthy audit keeps uncertainty alive, and the stock may trade with a discount until findings are out.<\/li>\n<li>Findings: an audit that confirms the company&#8217;s position would remove an overhang, while adverse findings could lead to further legal steps.<\/li>\n<li>Company disclosures: any exchange filing on legal proceedings in the matter will be the primary source of new information.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live prices, corporate announcements and price alerts for the stocks in this story.<\/em><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Fortis Healthcare forensic audit will go ahead after the Supreme Court&#8217;s order, but the court has also limited the weight of the High Court&#8217;s critical observations, and the company says it has no liability in the underlying case. The stock&#8217;s mild reaction shows that investors are waiting for the audit&#8217;s scope and findings, and until then the risk is about uncertainty rather than proven exposure. Track the company&#8217;s filings and its price levels on the Univest Screener.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_did_the_Supreme_Court_decide_about_the_Fortis_Healthcare_forensic_audit\"><\/span><strong>What did the Supreme Court decide about the Fortis Healthcare forensic audit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On 25 September 2026 the Supreme Court declined to interfere with the Delhi High Court&#8217;s 31 August order for a forensic audit, and said the audit must be independent of the High Court&#8217;s tentative observations.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_is_Fortis_Healthcares_position_in_the_Daiichi_dispute\"><\/span><strong>What is Fortis Healthcare&#8217;s position in the Daiichi dispute?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis says it was a complete stranger to the dispute, was never a party to the arbitration, is neither a judgment debtor nor a garnishee, and has had no liability, penalty or fine imposed on it.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Why_is_Daiichi_Sankyo_behind_the_Fortis_Healthcare_forensic_audit\"><\/span><strong>Why is Daiichi Sankyo behind the Fortis Healthcare forensic audit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Daiichi is trying to enforce a 2016 arbitral award against former promoters Malvinder and Shivinder Singh, and the enforcement widened to transactions involving the Singh brothers&#8217; shares in Fortis.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"How_did_the_Fortis_share_price_react_to_the_Fortis_Healthcare_forensic_audit_order\"><\/span><strong>How did the Fortis share price react to the Fortis Healthcare forensic audit order?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The shares were quoted at Rs 821, down Rs 14.10 or 1.69 percent, a mild move compared with the 18 percent intraday fall seen in September 2022 on an earlier audit order.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Is_Fortis_Healthcare_oversold\"><\/span><strong>Is Fortis Healthcare oversold?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 14-day RSI is about 22.3, which is below 30 and is read as oversold, and the price is about 7 percent below its 20-day average.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_is_Fortis_Healthcares_valuation\"><\/span><strong>What is Fortis Healthcare&#8217;s valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fortis trades at 58.89 times earnings against an industry multiple of 67.71, with return on equity of 10.53 percent and debt-to-equity of 0.35.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_should_investors_watch_next_in_the_Fortis_Healthcare_forensic_audit\"><\/span><strong>What should investors watch next in the Fortis Healthcare forensic audit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should watch who is appointed to conduct the audit, the transactions it covers, its timeline and any exchange filings from Fortis on the matter.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What did the Supreme Court decide about the Fortis Healthcare forensic audit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"On 25 September 2026 the Supreme Court declined to interfere with the Delhi High Court's 31 August order for a forensic audit, and said the audit must be independent of the High Court's tentative observations.\"}},{\"@type\":\"Question\",\"name\":\"What is Fortis Healthcare's position in the Daiichi dispute?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis says it was a complete stranger to the dispute, was never a party to the arbitration, is neither a judgment debtor nor a garnishee, and has had no liability, penalty or fine imposed on it.\"}},{\"@type\":\"Question\",\"name\":\"Why is Daiichi Sankyo behind the Fortis Healthcare forensic audit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Daiichi is trying to enforce a 2016 arbitral award against former promoters Malvinder and Shivinder Singh, and the enforcement widened to transactions involving the Singh brothers' shares in Fortis.\"}},{\"@type\":\"Question\",\"name\":\"How did the Fortis share price react to the Fortis Healthcare forensic audit order?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The shares were quoted at Rs 821, down Rs 14.10 or 1.69 percent, a mild move compared with the 18 percent intraday fall seen in September 2022 on an earlier audit order.\"}},{\"@type\":\"Question\",\"name\":\"Is Fortis Healthcare oversold?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The 14-day RSI is about 22.3, which is below 30 and is read as oversold, and the price is about 7 percent below its 20-day average.\"}},{\"@type\":\"Question\",\"name\":\"What is Fortis Healthcare's valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fortis trades at 58.89 times earnings against an industry multiple of 67.71, with return on equity of 10.53 percent and debt-to-equity of 0.35.\"}},{\"@type\":\"Question\",\"name\":\"What should investors watch next in the Fortis Healthcare forensic audit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should watch who is appointed to conduct the audit, the transactions it covers, its timeline and any exchange filings from Fortis on the matter.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Supreme Court cleared a forensic audit of Fortis in the Daiichi Sankyo case, while Fortis says it was a complete stranger to the dispute; the stock fell 1.69 percent.<\/p>\n","protected":false},"author":28,"featured_media":273263,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[1154,1019],"class_list":["post-273265","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-healthcare-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["273263"],"rank_math_title":["Fortis Healthcare Forensic Audit: What Investors Should Know"],"rank_math_description":["Fortis Healthcare forensic audit cleared by the Supreme Court in the Daiichi Sankyo case. What the order says, what Fortis says and the stock's levels."],"rank_math_focus_keyword":["Fortis Healthcare forensic audit"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/fortis-says-it-is-a-complete-stranger-to-the-daiichi-dispute-as-the-supreme.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=273265"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273265\/revisions"}],"predecessor-version":[{"id":273266,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273265\/revisions\/273266"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/273263"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=273265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=273265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=273265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}